SAM
BIIB icon

Storebrand Asset Management’s Biogen BIIB Stock Holding History

Storebrand Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Buy
15,812
+11,589
+274% +$2.22M 0.01% 546
2026
Q1 		$774K Buy
4,223
+175
+4% +$32.2K ﹤0.01% 648
2025
Q4 		$712K Buy
4,048
+1,713
+73% +$280K ﹤0.01% 660
2025
Q3 		$327K Buy
2,335
+1,272
+120% +$172K ﹤0.01% 704
2025
Q2 		$134K Sell
1,063
-1,982
-65% -$247K ﹤0.01% 741
2025
Q1 		$417K Sell
3,045
-17,921
-85% -$2.56M ﹤0.01% 713
2024
Q4 		$3.21M Sell
20,966
-34,383
-62% -$5.8M 0.01% 555
2024
Q3 		$10.7M Sell
55,349
-2,150
-4% -$450K 0.03% 377
2024
Q2 		$13.3M Sell
57,499
-41,879
-42% -$9.1M 0.04% 348
2024
Q1 		$21.4M Sell
99,378
-47,710
-32% -$11.2M 0.07% 271
2023
Q4 		$38.1M Sell
147,088
-406
-0.3% -$99.7K 0.14% 168
2023
Q3 		$37.9M Sell
147,494
-12,687
-8% -$3.39M 0.18% 142
2023
Q2 		$45.6M Buy
160,181
+10,954
+7% +$3.26M 0.21% 124
2023
Q1 		$41.5M Buy
149,227
+48,910
+49% +$13.5M 0.21% 126
2022
Q4 		$27.8M Buy
100,317
+38,055
+61% +$10.7M 0.15% 177
2022
Q3 		$16.6M Buy
62,262
+503
+0.8% +$107K 0.1% 246
2022
Q2 		$12.6M Sell
61,759
-3,840
-6% -$785K 0.07% 304
2022
Q1 		$13.8M Sell
65,599
-6,681
-9% -$1.45M 0.07% 307
2021
Q4 		$17.3M Sell
72,280
-31,471
-30% -$8.09M 0.08% 286
2021
Q3 		$29.4M Sell
103,751
-4,750
-4% -$1.56M 0.14% 168
2021
Q2 		$37.6M Sell
108,501
-11,054
-9% -$3.35M 0.18% 132
2021
Q1 		$33.4M Sell
119,555
-929
-0.8% -$251K 0.18% 131
2020
Q4 		$29.5M Buy
120,484
+20,784
+21% +$5.36M 0.17% 138
2020
Q3 		$28.3M Buy
99,700
+10,637
+12% +$2.97M 0.2% 115
2020
Q2 		$23.8M Buy
89,063
+17,746
+25% +$5.33M 0.2% 118
2020
Q1 		$22.6M Buy
+71,317
New +$21.6M 0.23% 100

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Storebrand Asset Management's BIIB Position: Q2 2026 in Review

Storebrand Asset Management increased its Biogen (BIIB) stake by 274% in Q2 2026, buying an estimated $2.22M and bringing the position to 15,812 shares worth $3.42M. The position accounts for 0.01% of the portfolio, ranked #546.

Storebrand Asset Management first reported a position in BIIB in Q1 2020 and has held it in 26 quarters since. The position peaked at $45.6M in Q2 2023. 981 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Storebrand Asset Management held 15,812 shares of Biogen worth $3.42M as of Q2 2026.
  • Storebrand Asset Management bought 11,589 Biogen shares in Q2 2026, an estimated $2.22M.
  • Biogen made up 0.01% of Storebrand Asset Management's portfolio in Q2 2026, its #546 holding.
  • Storebrand Asset Management first reported a position in Biogen in Q1 2020 and has held it in 26 quarters since.
  • Storebrand Asset Management's Biogen position peaked at $45.6M in Q2 2023.
  • 981 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.